VLPbio

About:

VLPbio focuses on research and development of chimeric virus like particles (VLPs) as vaccines in animal and human health.

Website: http://vlpbio.com/

Twitter/X: vlpbio

Top Investors: Inveready, EASME - EU Executive Agency for SMEs, Dyadic International

Description:

VLPbio focuses on research and development of chimeric virus like particles (VLPs) as vaccines in animal and human health. The company is well-known a biotechnological company applying immunotherapeutic solutions to fight cancer and infectious diseases, addressing unmet medical needs in the main human and veterinarian markets

Total Funding Amount:

850000 EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boecillo, Castilla y Leon, Spain

Founded Date:

2011-01-01

Contact Email:

info(AT)bdibiotech.co

Founders:

Pablo Gutierrez Gómez

Number of Employees:

1-10

Last Funding Date:

2018-02-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai